Stereochemistry | ACHIRAL |
Molecular Formula | C6H14FO3P |
Molecular Weight | 184.1457 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OP(F)(=O)OC(C)C
InChI
InChIKey=MUCZHBLJLSDCSD-UHFFFAOYSA-N
InChI=1S/C6H14FO3P/c1-5(2)9-11(7,8)10-6(3)4/h5-6H,1-4H3
Molecular Formula | C6H14FO3P |
Molecular Weight | 184.1457 |
Charge | 0 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Originator
Approval Year
Sourcing
PubMed
Sample Use Guides
Topical, to the conjunctiva, a thin strip (approximately 0.5 cm) of a 0.025% ointment once every three days to three times a day.
Route of Administration:
Topical
Recombinant AChE was quantitated using the extinction coefficient 119, 650 M-1 cm-1 calculated from its amino acid sequence. AChE (34 nM) was assayed using Ellman’s reagent using 160 uM acetylthiocholine and 300 uM 5,50-dithiobis-2-ntirobenzoic acid (DTNB). Thiocholine released by the enzyme reacts with excess DTNB, resulting in the formation of the thionitrobenzoate anion, which absorbs at 412 nm. To assess IC50, the inhibitors were solubilized in isopropanol and used in volumes of less than 5% of the total reaction volume. AChE (34 nM) was incubated for 30 min with each compound at an array of concentrations. The residual activity of the enzyme was assayed using 500 uM acetylthiocholine, a saturating concentration 10-fold higher than the Km of 46 uM for this substrate.